- Home
- VTS vs COLL Comparison
VTS vs COLL Comparison
Compare VTS & COLL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VTS
- COLL
- Stock Information
- Founded
- VTS 2014
- COLL 2002
- Country
- VTS United States
- COLL United States
- Employees
- VTS N/A
- COLL N/A
- Industry
- VTS Oil & Gas Production
- COLL Biotechnology: Pharmaceutical Preparations
- Sector
- VTS Energy
- COLL Health Care
- Exchange
- VTS Nasdaq
- COLL Nasdaq
- Market Cap
- VTS 937.5M
- COLL 958.8M
- IPO Year
- VTS N/A
- COLL 2015
- Fundamental
- Price
- VTS $24.19
- COLL $30.70
- Analyst Decision
- VTS Strong Buy
- COLL Strong Buy
- Analyst Count
- VTS 4
- COLL 4
- Target Price
- VTS $30.25
- COLL $43.75
- AVG Volume (30 Days)
- VTS 235.0K
- COLL 273.3K
- Earning Date
- VTS 08-04-2025
- COLL 08-07-2025
- Dividend Yield
- VTS 9.33%
- COLL N/A
- EPS Growth
- VTS N/A
- COLL N/A
- EPS
- VTS 0.76
- COLL 1.25
- Revenue
- VTS $225,502,000.00
- COLL $664,283,000.00
- Revenue This Year
- VTS $22.25
- COLL $20.23
- Revenue Next Year
- VTS N/A
- COLL $3.82
- P/E Ratio
- VTS $31.77
- COLL $24.46
- Revenue Growth
- VTS 4.90
- COLL 17.17
- 52 Week Low
- VTS $18.90
- COLL $23.23
- 52 Week High
- VTS $28.41
- COLL $42.29
- Technical
- Relative Strength Index (RSI)
- VTS 56.23
- COLL 45.95
- Support Level
- VTS $23.42
- COLL $30.75
- Resistance Level
- VTS $25.01
- COLL $32.66
- Average True Range (ATR)
- VTS 0.54
- COLL 0.82
- MACD
- VTS 0.07
- COLL -0.20
- Stochastic Oscillator
- VTS 64.29
- COLL 6.10
About VTS Vitesse Energy Inc.
Vitesse Energy Inc is an independent energy company focused on returning capital to stockholders through owning interests as a non-operator in oil and natural gas wells. It is engaged in the acquisition, development, and production of non-operated oil and natural gas properties in the United States that are generally operated by oil companies and are in the Williston Basin of North Dakota and Montana. The company also have properties in the Central Rockies, including the Denver-Julesburg Basin and the Powder River Basin.
About COLL Collegium Pharmaceutical Inc.
Collegium Pharmaceutical Inc is a specialty pharmaceutical company. The company is engaged in developing and planning to commercialize abuse-deterrent products that incorporate its patented DETERx platform technology for the treatment of chronic pain and other diseases. The DETERx platform technology is designed to maintain the extended-release and safety profiles of abused drugs in the face of various methods including chewing, crushing, and dissolving. Its product portfolio includes Jornay, Xtampza ER, which is an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta Products, which are extended-release and immediate-release formulations of tapentadol; Belbuca, and Symproic.